VRSN insider filing: VeriSign CEO reports November stock sales
Rhea-AI Filing Summary
VeriSign, Inc. (VRSN) reported insider stock sales by its Executive Chairman, President, and CEO, D. James Bidzos. A Form 4 filing shows a series of open‑market sales of VeriSign common stock on November 18–20, 2025, totaling 9,000 shares. Individual trades ranged from 80 to 2,705 shares per transaction.
The reported weighted average sale prices ranged from about $244.47 to $251.33 per share, with detailed price ranges provided for each trade. After these transactions, Bidzos beneficially owned approximately 438,966.4829 shares of VeriSign common stock in direct form.
Positive
- None.
Negative
- None.
Insights
Analyzing...
FAQ
What did VeriSign (VRSN) disclose in this Form 4 filing?
The Form 4 reports that VeriSign’s Executive Chairman, President, and CEO, D. James Bidzos, sold shares of VeriSign common stock in a series of open‑market transactions on November 18–20, 2025.
How many VeriSign (VRSN) shares did the CEO sell in this period?
The transactions listed in the Form 4 total 9,000 shares of VeriSign common stock sold across multiple trades between November 18 and November 20, 2025.
At what prices were the VeriSign (VRSN) shares sold by the CEO?
The filing reports weighted average prices for each trade, with transaction price ranges from $244.47 to $251.33 per share, and notes that detailed per‑trade prices are available to the SEC on request.
How many VeriSign (VRSN) shares does the CEO own after these sales?
After the reported transactions, D. James Bidzos beneficially owned 438,966.4829 shares of VeriSign common stock, held in direct ownership.
What is the role of the reporting person in VeriSign (VRSN)?
The reporting person, D. James Bidzos, is identified as a Director and an Officer of VeriSign, with the title Executive Chairman, President, & CEO.
Were these VeriSign (VRSN) transactions reported as non‑derivative or derivative securities?
The filing lists the reported transactions in Table I – Non‑Derivative Securities as sales of VeriSign common stock. Table II – Derivative Securities shows no derivative transactions reported in this excerpt.
How are the sale prices described in the VeriSign (VRSN) Form 4?
For each line item, the Form 4 states the weighted average price and provides the range of actual sale prices, with a note that full per‑trade details will be provided to the SEC upon request.